VR-based Remote Rehabilitation for Pediatric ABI

December 9, 2023 updated by: Libra At Home LTD

Virtual Reality Based Rehabilitation of Vestibular and Oculomotor Function for Pediatric ABI in a Home Setting

The primary objective of this study is to evaluate the feasibility and effectiveness of an at-home program of VR-based vestibular and oculomotor rehabilitation on improving postural stability, ocular motility and activities of daily living for children with mild to severe ABI

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jerusalem, Israel
        • ALYN Hospital Pediatric and Adolescent Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • They are ALYN patients undergoing physiotherapy for mild to severe ABI;
  • They experience symptoms of vestibular function such as vertigo, postural instability, or impaired ocular motility;
  • They are between the ages of 8 and 18;
  • The time since injury/event is between 10 days and 1 year after the injury/event;
  • They are able to maintain stable and dynamic positioning of the head;
  • They able to walk with or without assistive equipment, or use a wheelchairs with no need for head support, defined by a LSS (level of sitting scale) score of 3 or greater (scale range: 1-8);
  • Are able to understand basic instructions;
  • Have sufficient visual acuity and visual field to identify and track mid-size objects on a screen.

Exclusion Criteria:

  • Psychological, neurological or cognitive disorders which could impede participation, such as a history of epileptic seizures;
  • Untreated benign paroxysmal positional vertigo (BPPV);
  • Are in early post-operative stages (to avoid risk of bleeding or cerebrospinal fluid leak);
  • Hearing impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study
Exercises

LibraVR is a standalone VR-based rehabilitation software for use in physiotherapy. It is designed to work with standard off-the-shelf hardware that is tested and approved for use in conjunction with the software.

LibraVR system consists of the software (LibraVR Clinic) running on a PC (database of patients, creation of protocols, uploading protocols to mobile), and the LibraVR Mobile APP that runs on commercial mobile smartphones embedded in a lightweight cardboard or plastic VR viewer that the child wears as they would eyeglasses. The software displays a range of immersive VR exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vestibular Oculomotor Motor Screening (VOMS)
Time Frame: 6 months
Symptoms scoring from 0 (none) to 10 (severe)
6 months
Pediatric Vestibular Symptom Questionnaire (PVSQ)
Time Frame: 6 months
Score ranging from 0 (never) to 33 (most of the time) with a 4-Likert scale
6 months
Convergence Insufficiency Symptom Survey (CISS)
Time Frame: 6 months
Score ranging from 0 (never) to 56 (Always) with a 5-Likert scale
6 months
Dizziness Handicap Inventory (DHI)
Time Frame: 6 months
Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale
6 months
Dizziness Handicap Inventory for patients caregivers (DHI-PC)
Time Frame: 6 months
Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale
6 months
Pediatric Quality of Life Inventory (PEDSQL)
Time Frame: 6 months
Score ranging from 0 (worst) to 100 (best) with a 5-Likert scale
6 months
Modified Clinical Test of Sensory Interaction in Balance (mCTSIB)
Time Frame: 6 months
Time score ranging from 0 (unable to complete) to 120 (completed successfully) in one of three 30-seconds trials and four conditions
6 months
Berg Balance Scale (Berg)
Time Frame: 6 months
Score ranging from 0 (lowest level of function) to 56 (highest level of function) with a 5-Likert scale
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Naomi Gefen, ALYN Hospital Pediatric and Adolescent Rehabilitation Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2021

Primary Completion (Actual)

December 15, 2022

Study Completion (Actual)

April 1, 2023

Study Registration Dates

First Submitted

August 25, 2021

First Submitted That Met QC Criteria

September 12, 2021

First Posted (Actual)

September 22, 2021

Study Record Updates

Last Update Posted (Estimated)

December 12, 2023

Last Update Submitted That Met QC Criteria

December 9, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe